The Sabin Vaccine Institute announced a new research project with the Kenya Medical Research Institute (KEMRI) to optimize the use of the oral cholera vaccine. The research aims to inform vaccination strategies that could be beneficial in tackling the global resurgence in cholera as well as acute vaccine shortages. The World Health Organization (WHO) currently...
The World Health Organization reports there were 473 000 cases of cholera — an acute diarrheal disease that can kill within hours if untreated — in 2022. That is double the number from 2021, and it is estimated to have almost doubled again in 2023, now up to 700,000 cases. Currently, 23 countries are reporting cholera outbreaks, including the Democratic Republic of...
Almost as soon as the mainstream media deemed that “the unvaccinated can’t be persuaded,” declaring everyone who still hasn’t received at least one dose of the COVID-19 vaccine a lost cause no longer worthy of our concern, the media narrative quickly shifted its Southern fixation away from our handling of the pandemic. The polarization and...
LONGMONT, Colo (June 16, 2021) – Today, the African American Research Collaborative (AARC) and The Commonwealth Fund released findings from the just-completed 2021 American COVID-19 Vaccine Poll — an expansive poll designed to understand the barriers that prevent Americans from getting the COVID-19 vaccine. First Nations Development Institute (First Nations)...
Sabin Vaccine Institute Receives up to $6.3 Million from CEPI for Dose-Optimizing COVID-19 Vaccine Clinical Trial
Source link
Sabin Receives Additional $21.8 Million From BARDA to Advance Marburg Vaccine
Source link
Vaccine R&D Leader Kathrin Jansen and Immunologist Kizzmekia Corbett Awarded Sabin’s Gold Medal and Rising Star Respectively
Source link
Sabin Vaccine Institute Delivers Ebola Sudan Vaccine to Fight Outbreak in Uganda
Source link
The Sabin Vaccine Institute today announced that the Biomedical Advanced Research and Development Authority (BARDA) has awarded Sabin a multi-year contract with funding potential for up to $214 million to advance the development and production of single-dose vaccine candidates for Ebola Sudan and Marburg virus diseases. There are currently no licensed vaccines...
Nominations for the prestigious annual Albert B. Sabin Gold Medal and the Sabin Rising Star Award are now open. These annual awards from the Sabin Vaccine Institute recognize those who have made extraordinary contributions in the field of vaccinology or a complementary field such as infectious disease or public health. The Sabin Gold Medal commemorates the legacy of...